Search results

Narrow your search

Result types

Showing 221 - 230 of 555 for "Kim & Chang" with applied filters

News & Analysis

Delivery Platform Workers win Employee Status

08 August 2023 by LC Lawyers - Rossana Chu (Managing partner), Jacky Chan (Associate)

The Labour Tribunal recently ruled in favor of 6 workers (“Couriers”) who worked for a food and parcel delivery platform company (“Company”).

News & Analysis

The Future of the Food Industry: Food Tech

27 July 2023 by Lee & Ko

With significant development in dietary supplements and alternative food industry in recent years, Korean government announced alternative food (e.g., plant-based meet, cultured meat, insect based meat, etc.), dietary supplement and medical food (i.e., specially formulated food for patients with certain symptoms or nutritional needs) as industry sectors for future development.

News & Analysis

Strengthening Regulation of Unfair Trading through Amendment of FISCMA

24 July 2023 by Lee & Ko - South Korea

A proposal for partial amendment (Amendment) to the Financial Investment Services and Capital Markets Act (FISCMA) for the purpose of strengthening the regulation of unfair trading passed the plenary session of the National Assembly of Korea on June 30, 2023 and was promulgated on July 18, 2023.

News & Analysis

Enactment of the Special Act on the Promotion of Dispersed Energy & Amendment to Electric Utility Act

05 July 2023 by Lee & Ko - South Korea

The Special Act on the Promotion of Dispersed Energy (the Dispersed Energy Act) was recently enacted as of June 13, 2023 and, on the same date, the amendment to the Electric Utility Act (also known as the Electricity Business Act) (the Amendment) was also promulgated, both of which will come into force as of June 14, 2024.

News & Analysis

Trademark protection of signature poses and voices of celebrities in India: An uncharted territory

08 June 2023 by Rahul Chaudhry & Partners - India: Sakshi Mathur, Associate

Personality rights, commonly known as ‘right of publicity,’ guarantees an individual right in one’s personal attributes such as appearance, signature, voice, silhouette, face, features, gestures, expressions, mannerisms etc, paving way for an individual to use and commercialise one’s identity.

News & Analysis

Latest Update to “Guidelines for Workplace Risk Assessment“ to Impact Businesses in Korea

31 May 2023 by Lee & Ko - South Korea

On 22 May 2023, the Ministry of Employment and Labor (MOEL) announced a significant update to its “Guidelines for Workplace Risk Assessment“ (Guidelines), effective immediately.

News & Analysis

IP Issues and Implications Relating to ChatGPT

26 May 2023 by Lee & Ko - South Korea

ChatGPT is a conversational artificial intelligence (AI) service based on Generative Pre-trained Transformer (GPT), a language model grounded in artificial neural networks, developed by OpenAI.

News & Analysis

Advised on MBK Partners’ KRW 2.5 Trillion Acquisition of Leading Global Dental Scanner Developer Medit Corporation from UCK Partners

25 May 2023 by Kim & Chang - South Korea

Kim & Chang, using separate teams, advised both the buyer, MBK Partners, and the sellers, UCK Partners (formerly known as Unison Capital Korea) and individual shareholders, in connection with the purchase and sale of Medit Corporation (the “Target Company”).

News & Analysis

Patenting Molecular Diagnostics

17 May 2023 by LexOrbis - DPS Parmar

The patent eligibility in every jurisdiction differs in content and form. It perhaps finds its justification in the stage of development the country is placed in relation to inventions of new technology or its adoption by the state technology groups.

News & Analysis

Product Hopping and Ever-Greening of Patents in India

20 April 2023 by LexOrbis - Arun Kumar (Managing associate)

The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.